Jason Zemansky

Q: What is Jason Zemansky's success rate?

Jason Zemansky currently has a success rate of 78.5298300048005.

Q: What is the average return of Jason Zemansky's calls?

Their stock ratings have generated an average return of 20.970472963839484.

B of A Securities | Healthcare

Jason Zemansky is an analyst from B of A Securities specializing in the Healthcare sector. Ranked #2011 out of 4773 analysts, they have issued 14 stock ratings with a success rate of 78.53% and an average return of 20.97%.

With 14 ratings to date, Jason Zemansky is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 78.53% and an average return of 20.97%, highlighting promising potential as their track record develops further.

#2011

Out of 4773

Total Ratings

+78.53%

Success Rate

+20.97%

Average Return

Recent Ratings Analysis

BIIB

Hold

Jul 21, 2026

Target

$215.00

Current

$217.15

Performance

6.89%

Jason Zemansky rated BIIB as Neutral on Jul 21, 2026, setting a price target of 215. Despite the Hold call, shares climbed 6.89% to 217.15, revealing unexpected momentum.

LGND

Buy

Jul 09, 2026

Target

$388.00

Current

$284.47

Performance

-11.82%

On Jul 09, 2026, LGND was given a Buy rating by Jason Zemansky, with a target price of 388. Despite the Buy call, shares fell from 284.47 to 284.47, challenging the optimistic stance.

BMRN

Buy

May 19, 2026

Target

$80.00

Current

$65.68

Performance

31.86%

BMRN received a Buy rating from Jason Zemansky on May 19, 2026, aiming for 80. Momentum has favored the Buy call, with shares climbing from 65.68 to 65.68, rewarding those who trusted the recommendation.

RCKT

Buy

Mar 30, 2026

Target

$9.00

Current

$3.35

Performance

-2.90%

On Mar 30, 2026, Jason Zemansky published a Buy outlook on RCKT, with a target of 9. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 3.35.

INSM

Buy

Mar 24, 2026

Target

$213.00

Current

$129.41

Performance

-6.99%

Jason Zemansky on Mar 24, 2026 assigned INSM a Buy rating, with a price target of 213. The call has struggled to gain traction, with shares losing 6.99%.

EIKN

Buy

Mar 02, 2026

Target

$34.00

Current

$8.94

Performance

-39.92%

On Mar 02, 2026, Jason Zemansky reaffirmed EIKN with a Buy rating, targeting 34. Shares slid 39.92% despite the recommendation, highlighting downside risks.

IKT

Buy

Jan 21, 2026

Target

$6.00

Current

$2.34

Performance

33.71%

IKT was rated Buy by Jason Zemansky on Jan 21, 2026, with a price objective of 6. A bullish response from the market helped close the gap of 3.66 to the target.

KROS

Hold

Nov 28, 2025

Target

$19.00

Current

$11.08

Performance

-36.61%

On Nov 28, 2025, Jason Zemansky initiated coverage on KROS with a Neutral rating and target of 19. The rating matched the stock’s inability to hold above 11.08.

RCUS

Hold

Nov 28, 2025

Target

$26.00

Current

$24.59

Performance

-5.79%

Jason Zemansky issued a Neutral recommendation for RCUS on Nov 28, 2025, price target set at 26. Market action validated the conservative Hold outlook with shares at 24.59.

HOWL

Buy

Nov 18, 2025

Target

$7.00

Current

$0.98

Performance

7.30%

On Nov 18, 2025, HOWL was evaluated by Jason Zemansky, who gave a Buy rating and target of 7. This case illustrates how a timely bullish rating can translate into tangible gains of 7.30%.

CYTK

Hold

Oct 02, 2025

Target

$56.00

Current

$73.77

Performance

30.98%

Jason Zemansky rated CYTK as Neutral on Oct 02, 2025, setting a price target of 56. Despite the Hold call, shares climbed 30.98% to 73.77, revealing unexpected momentum.

KURA

Buy

Nov 22, 2024

Target

$29.00

Current

$11.39

Performance

5.46%

On Nov 22, 2024, KURA was given a Buy rating by Jason Zemansky, with a target price of 29. The stock rallied 5.46% after the rating, narrowing the gap to the target of 29 and validating the bullish stance.

SNDX

Buy

Aug 15, 2024

Target

$31.00

Current

$18.18

Performance

-8.92%

SNDX received a Buy rating from Jason Zemansky on Aug 15, 2024, aiming for 31. The rating hasn’t played out as hoped, with the stock trading 8.92% below expectations.

ESPR

Sell

Jun 20, 2024

Target

$2.50

Current

$3.18

Performance

38.86%

On Jun 20, 2024, Jason Zemansky published a Underperform outlook on ESPR, with a target of 2.5. Investors who followed the Sell rating avoided losses as the stock weakened.

Frequency Asked Questions

Who is Jason Zemansky?

Jason Zemansky is an analyst from B of A Securities specializing in the Healthcare sector.

What is Jason Zemansky's success rate?

Jason Zemansky currently has a success rate of +78.53%.

How many ratings has Jason Zemansky issued?

Jason Zemansky has issued 14 stock ratings so far.

What is the average return of Jason Zemansky's calls?

Their stock ratings have generated an average return of +20.97%.

What is Jason Zemansky's ranking?

Jason Zemansky is ranked #2011 out of 4773 analysts.

What types of ratings does Jason Zemansky give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Jason Zemansky?

You can follow Jason Zemansky by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Jason Zemansky?

Their latest rating was a Hold on BIIB issued on 2026-07-21.